Characteristics of gastrointestinal T or NK/T cell lymphoma and an influence of Helicobacter pylori infection

胃肠道T或NK/T细胞淋巴瘤的特点及幽门螺杆菌感染的影响

基本信息

  • 批准号:
    21590390
  • 负责人:
  • 金额:
    $ 1.75万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2009
  • 资助国家:
    日本
  • 起止时间:
    2009 至 2011
  • 项目状态:
    已结题

项目摘要

Coeliac disease and associating enteropathy-associated T-cell lymphoma(EATL) are frequently found in European Caucasians. Approximately 80% of enteropathy-associated T-cell lymphoma(EATL) cases present with CD56-negative, CD8-negative and CD30-positive large-cell lymphoma(type I). The remaining cases are classified as type II EATL and they present with CD56-and CD8-positive and CD30-negative monomorphic medium-sized lymphomas. In examined 32 cases of Japanese EATL, type II(CD56-and CD8-positive, CD30-negative medium-sized) lymphoma was common(85%) in Japan. HLA DQB102 homo-, heterozygosities and chromosomal amplification of 9q33-34, which are encountered in the Caucasian cases, were absent in the examined cases of Japanese EATL. Asian EATL cases are associated with peculiar pathological and genetic findings as well as histological features. Bacterial cytotoxic associated gene(Cag) A of East Asian H. pylori contributes to neoplastic transformation of gastric epithelium through the proto-oncogene c-Met, tyrosine kinase(p-SHP) 2 and mitogen-activated protein kinase(MAPK) pathway. Enteropathy-like lesions and CagA of East Asian H. pylori were detected in about half cases of tumor tissue in EATL, and expressions of c-Met, p-SHP2 and MAPK as well as chromosomal amplifications of c-Met(7q31) and c-Myc(8q24) were frequently found in cases of EATL. Intestinal bacterial florae including H. pylori may influence tumorgenesis in EATL.
乳糜泻和相关肠病相关T细胞淋巴瘤(EATL)常见于欧洲高加索人。大约80%的肠病相关T细胞淋巴瘤(EATL)病例表现为CD 56阴性、CD 8阴性和CD 30阳性大细胞淋巴瘤(I型)。其余病例归类为II型EATL,表现为CD 56和CD 8阳性和CD 30阴性单形中型淋巴瘤。在检查的32例日本EATL中,II型(CD 56和CD 8阳性,CD 30阴性中型)淋巴瘤在日本很常见(85%)。在日本EATL患者中,没有发现白种人病例中常见的HLA-DQB 102纯合性、杂合性和9 q33 -34染色体扩增。亚洲EATL病例与特殊的病理学和遗传学发现以及组织学特征相关。东亚血吸虫的细菌细胞毒性相关基因(Cag)A。幽门螺杆菌通过原癌基因c-Met、酪氨酸激酶(p-SHP)2和丝裂原活化蛋白激酶(MAPK)途径参与胃上皮的肿瘤转化。东亚H. pylori阳性率约为50%; c-Met、p-SHP 2和MAPK的表达以及c-Met(7 q31)和c-Myc(8 q24)的染色体扩增在EATL中较常见。肠道菌群包括H. pylori可能影响EATL的肿瘤发生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
小腸における腸管症関連T細胞リンパ腫の細胞形質、腸管症様病変の臨床病理学的検討
小肠肠病相关 T 细胞淋巴瘤的细胞病理学和肠病样病变的临床病理学检查
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    菊間幹太、山田梢、二村聡、竹下盛重;他
  • 通讯作者:
下肢の出血班。ダイナミック病理学
下肢有出血点。
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    賀屋大介;福岡宏倫;藤井澄;大森斉;國安弘基;竹下盛重
  • 通讯作者:
    竹下盛重
腸管症関連T細胞リンパ腫のCHGH法による検討
采用 CHGH 法研究肠病相关 T 细胞淋巴瘤
小腸腸管症関連T細胞リンパ腫(EATL)の臨床病理学的検討
肠病相关T细胞淋巴瘤(EATL)的临床病理学研究
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    宇月美和;佐々木喜子;越智隆弘;澤井高志;竹下盛重
  • 通讯作者:
    竹下盛重
Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma : correlation with clinicopathologic features in 48 patients
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    梁井 俊一
  • 通讯作者:
    梁井 俊一
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKESHITA Morishige其他文献

TAKESHITA Morishige的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKESHITA Morishige', 18)}}的其他基金

Clinicopathologic characteristics of γ/δ T-cell lymphoma
γ/δ T细胞淋巴瘤的临床病理特征
  • 批准号:
    17590322
  • 财政年份:
    2005
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidation of Novel Therapeutic Targets for Primary Intraocular Malignant Lymphoma Based on Analysis of B Cells within Tertiary Lymphoid Structures
基于三级淋巴结构内 B 细胞的分析阐明原发性眼内恶性淋巴瘤的新治疗靶点
  • 批准号:
    23K15921
  • 财政年份:
    2023
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Realization of Quantitatively Evaluation Criteria for Atypia based on Morphological Features of Cellular Tissue towards the Construction of Morphology in Malignant Lymphoma
实现基于细胞组织形态特征的异型性定量评价标准,构建恶性淋巴瘤形态学
  • 批准号:
    23KJ1141
  • 财政年份:
    2023
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of novel therapeutic approach for refractory anemia and malignant lymphoma by targeting ferroptosis suppressor protein-1
以铁死亡抑制蛋白-1为靶点开发难治性贫血和恶性淋巴瘤的新治疗方法
  • 批准号:
    22KK0270
  • 财政年份:
    2023
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Comprehensive elucidation of molecular pathogenesis based on genetic abnormalities in malignant lymphoma
基于恶性淋巴瘤基因异常全面阐明分子发病机制
  • 批准号:
    21H05051
  • 财政年份:
    2021
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Evaluation of minimal residual disease by liquid biopsy in malignant lymphoma for precise therapeutic stratification.
通过液体活检评估恶性淋巴瘤的微小残留病,以进行精确的治疗分层。
  • 批准号:
    21K08407
  • 财政年份:
    2021
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation for spontaneous regression of malignant lymphoma
恶性淋巴瘤自然消退的研究
  • 批准号:
    21K16260
  • 财政年份:
    2021
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exploring association of ganglioside in cutaneous malignant lymphoma with tumor immunology
探索皮肤恶性淋巴瘤中神经节苷脂与肿瘤免疫学的关系
  • 批准号:
    21K08300
  • 财政年份:
    2021
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional role of PD-L1 alteration in the pathogenesis of malignant lymphoma
PD-L1改变在恶性淋巴瘤发病机制中的功能作用
  • 批准号:
    20K17415
  • 财政年份:
    2020
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Eludation of organ tropism from the diversity of malignant lymphoma and its application to novel treatment
从恶性淋巴瘤的多样性中揭示器官向性及其在新治疗中的应用
  • 批准号:
    20K08751
  • 财政年份:
    2020
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A development of a gene mutations-targeted novel therapy in malignant lymphoma
恶性淋巴瘤基因突变靶向新疗法的开发
  • 批准号:
    20K17409
  • 财政年份:
    2020
  • 资助金额:
    $ 1.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了